Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
1148 Views
eMediNexus 17 February 2019
Oral complications such as osteonecrosis of the jaw (ONJ) are rare in women taking medications for postmenopausal osteoporosis, according to a study published in the Journal of Clinical Endocrinology & Metabolism. Researchers used data from the seven-year FREEDOM Extension trial to assess information on oral procedures and cases of ONJ in women taking denosumab for postmenopausal osteoporosis. They found 45% of patients had at least one invasive dental procedure, but the overall rate of ONJ was low.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}